ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants X Luo, S Feurstein, S Mohan, CC Porter, SA Jackson, S Keel, M Chicka, ... Blood advances 3 (20), 2962-2979, 2019 | 133 | 2019 |
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies MW Drazer, S Kadri, M Sukhanova, SA Patil, AH West, S Feurstein, ... Blood advances 2 (2), 146-150, 2018 | 108 | 2018 |
Germline ETV6 mutations and predisposition to hematological malignancies S Feurstein, LA Godley International journal of hematology 106, 189-195, 2017 | 86 | 2017 |
Genetic predisposition to leukemia and other hematologic malignancies S Feurstein, MW Drazer, LA Godley Seminars in Oncology 43 (5), 598-608, 2016 | 76 | 2016 |
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages S Feurstein, AM Trottier, N Estrada-Merly, M Pozsgai, K McNeely, ... Blood, The Journal of the American Society of Hematology 140 (24), 2533-2548, 2022 | 58 | 2022 |
Germline variants drive myelodysplastic syndrome in young adults S Feurstein, JE Churpek, T Walsh, S Keel, M Hakkarainen, T Schroeder, ... Leukemia 35 (8), 2439-2444, 2021 | 53 | 2021 |
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer D Singhal, CN Hahn, S Feurstein, LYA Wee, L Moma, MM Kutyna, ... Leukemia 35 (11), 3245-3256, 2021 | 43 | 2021 |
GATA2 deficiency syndrome: a decade of discovery CC Homan, P Venugopal, P Arts, NH Shahrin, S Feurstein, L Rawlings, ... Human Mutation 42 (11), 1399-1421, 2021 | 37 | 2021 |
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations S Feurstein, A Adegunsoye, D Mojsilovic, R Vij, AH West DePersia, ... Blood Advances 4 (19), 4873-4886, 2020 | 33 | 2020 |
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies AM Trottier, LJ Druhan, IL Kraft, A Lance, S Feurstein, M Helgeson, ... Blood Advances 4 (20), 5269-5284, 2020 | 28 | 2020 |
Germline predisposition to hematopoietic malignancies S Feurstein, M Drazer, LA Godley Human molecular genetics 30 (R2), R225-R235, 2021 | 25 | 2021 |
How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline … D Wu, X Luo, S Feurstein, C Kesserwan, S Mohan, DE Pineda-Alvarez, ... Haematologica 105 (4), 870, 2020 | 25 | 2020 |
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype S Feurstein, FG Rücker, L Bullinger, W Hofmann, G Manukjan, G Göhring, ... BMC genomics 15, 1-11, 2014 | 25 | 2014 |
Clonal heterogeneity in childhood myelodysplastic syndromes—Challenge for the detection of chromosomal imbalances by array‐CGH I Praulich, M Tauscher, G Göhring, S Glaser, W Hofmann, S Feurstein, ... Genes, Chromosomes and Cancer 49 (10), 885-900, 2010 | 18 | 2010 |
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia Y Kubota, M Zawit, J Durrani, W Shen, W Bahaj, T Kewan, B Ponvilawan, ... Leukemia 36 (12), 2827-2834, 2022 | 14 | 2022 |
Accurate germline RUNX1 variant interpretation and its clinical significance S Feurstein, L Zhang, CD DiNardo Blood Advances 4 (24), 6199-6203, 2020 | 13 | 2020 |
A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias S Feurstein, CN Hahn, N Mehta, LA Godley Genetics in Medicine 24 (4), 931-954, 2022 | 11 | 2022 |
Routes of clonal evolution into complex karyotypes in myelodysplastic syndrome patients with 5q deletion S Feurstein, K Thomay, W Hofmann, G Buesche, H Kreipe, F Thol, ... International Journal of Molecular Sciences 19 (10), 3269, 2018 | 10 | 2018 |
Revision of RUNX1 variant curation rules S Feurstein, X Luo, M Shah, T Walker, N Mehta, D Wu, LA Godley Blood Advances 6 (16), 4726-4730, 2022 | 9 | 2022 |
Emerging bone marrow failure syndromes-new pieces to an unsolved puzzle S Feurstein Frontiers in Oncology 13, 1128533, 2023 | 3 | 2023 |